玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

OMAPATRILAT

    
≥97%

OMAPATRILAT

源葉(MedMol)
S83848 一鍵復制產品信息
167305-00-2
C19H24N2O4S2
408.535
VANLEV;OMAPATRILAT/VANLEV;BMS 186716-01
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S83848-5mg
≥97% ¥820.00 貨期:2-3天 - - -
S83848-10mg
≥97% ¥1450.00 貨期:2-3天 - - -
S83848-25mg
≥97% ¥3100.00 貨期:2-3天 - - -
S83848-50mg
≥97% ¥5580.00 貨期:2-3天 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

Omapatrilat is a dual inhibitor of the metalloproteases ACE and NEP with Ki values of 0.64 and 0.45 nM, respectively.

產品描述: Omapatrilat is a dual inhibitor of the metalloproteases ACE and NEP with Ki values of 0.64 and 0.45 nM, respectively.
靶點: Ki: 0.45 nM (NEP), 0.64 nM (ACE); IC50: 8 nM (NEP), 5 nM (ACE);RAAS
體內研究: Omapatrilat demonstrates excellent blood pressure lowering in a variety of animal models characterized by various levels of plasma renin activity and significantly potentiates urinary sodium, ANP, and cGMP excretion in a cynomolgus monkey assay. Omapatrilat decreases mean arterial pressure (MAP) approximately 40 mmHg below baseline from 10 to 24 h. Oral administration of omapatrilat at 100 μM/kg once daily results in a 38 mmHg decrease in systolic blood pressure at day three as compared to vehicle. Omapatrilat is widely used in experimental protocols related to hypertension and heart failure. Chronic oral administration of omapatrilat reduces aortic leakiness and atheroma formation with enhanced endothelial independent vasorelaxation to ANP. Omapatrilat causes significant inhibition of plasma ACE and increased plasma renin activity in rats
參考文獻: 1. Fryer RM, et al. Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy ofenzymes associated with bradykinin-mediated angioedema.Br J Pharmacol. 2008 Mar;153(5):947-55. 2. Robl JA, et al. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics asinhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem. 1997 May 23;40(11):1570-7. 3. Ichiki T, et al. Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis. Peptides. 2013 Oct;48:21-6. 4. Burrell LM, et al. Antihypertensive and antihypertrophic effects of omapatrilat in SHR. Am J Hypertens. 2000 Oct;13(10):1110-6.
溶解性: Soluble  in  DMSO
保存條件: 2-8℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.448 ml 12.239 ml 24.478 ml
5 mM 0.49 ml 2.448 ml 4.896 ml
10 mM 0.245 ml 1.224 ml 2.448 ml
50 mM 0.049 ml 0.245 ml 0.49 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 银川市| 浑源县| 都兰县| 右玉县| 贵阳市| 安溪县| 阜新市| 修文县| 嵊泗县| 莲花县| 崇州市| 木兰县| 堆龙德庆县| 浦东新区| 峨眉山市| 崇明县| 丰原市| 自贡市| 闽侯县| 庄河市| 那曲县| 扶沟县| 出国| 勐海县| 石台县| 浠水县| 西乌珠穆沁旗| 沈丘县| 磐石市| 广丰县| 贵港市| 西乌珠穆沁旗| 关岭| 宝坻区| 聂荣县| 沁源县| 莆田市| 克什克腾旗| 黔西| 凌云县| 合山市|